Agilent Technologies Inc (NYSE:A) saw unusually large options trading activity on Thursday. Stock investors acquired 3,726 call options on the company. This is an increase of 633% compared to the typical daily volume of 508 call options.
A number of analysts recently weighed in on the stock. Cfra dropped their price objective on shares of Agilent Technologies from $89.00 to $85.00 and set a “hold” rating on the stock in a report on Friday. HSBC raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Wednesday, February 12th. Royal Bank of Canada assumed coverage on shares of Agilent Technologies in a report on Tuesday, April 28th. They issued a “sector perform” rating on the stock. Citigroup dropped their price objective on shares of Agilent Technologies from $85.00 to $75.00 and set a “neutral” rating on the stock in a report on Friday, March 20th. Finally, UBS Group increased their price objective on shares of Agilent Technologies from $84.00 to $87.00 and gave the stock a “neutral” rating in a report on Friday. Eleven research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $85.75.
In related news, CEO Michael R. Mcmullen sold 18,018 shares of the stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $80.00, for a total value of $1,441,440.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, VP Mark Doak sold 3,494 shares of the stock in a transaction dated Tuesday, March 3rd. The stock was sold at an average price of $83.81, for a total transaction of $292,832.14. Following the completion of the sale, the vice president now directly owns 135,678 shares in the company, valued at approximately $11,371,173.18. The disclosure for this sale can be found here. Insiders have sold 43,929 shares of company stock worth $3,476,727 over the last three months.
Several large investors have recently bought and sold shares of A. CENTRAL TRUST Co boosted its position in shares of Agilent Technologies by 46.6% during the 4th quarter. CENTRAL TRUST Co now owns 2,837 shares of the medical research company’s stock valued at $242,000 after purchasing an additional 902 shares in the last quarter. Exchange Traded Concepts LLC acquired a new position in shares of Agilent Technologies in the fourth quarter worth about $643,000. Clarius Group LLC acquired a new position in shares of Agilent Technologies in the fourth quarter worth about $232,000. S.E.E.D. Planning Group LLC acquired a new position in shares of Agilent Technologies in the fourth quarter worth about $2,452,000. Finally, FinTrust Capital Advisors LLC boosted its holdings in shares of Agilent Technologies by 450.7% in the fourth quarter. FinTrust Capital Advisors LLC now owns 380 shares of the medical research company’s stock worth $32,000 after buying an additional 311 shares during the period.
NYSE:A opened at $84.98 on Friday. Agilent Technologies has a twelve month low of $61.13 and a twelve month high of $90.64. The company has a current ratio of 1.64, a quick ratio of 1.27 and a debt-to-equity ratio of 0.37. The company has a 50-day moving average of $77.33 and a 200-day moving average of $79.96. The firm has a market cap of $25.00 billion, a price-to-earnings ratio of 39.16 and a beta of 1.10.
Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Thursday, May 21st. The medical research company reported $0.71 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.61 by $0.10. Agilent Technologies had a net margin of 13.04% and a return on equity of 20.75%. The company had revenue of $1.24 billion during the quarter, compared to analyst estimates of $1.20 billion. During the same quarter last year, the firm posted $0.71 EPS. The business’s revenue for the quarter was up .2% on a year-over-year basis. On average, research analysts forecast that Agilent Technologies will post 2.95 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.18 per share. The ex-dividend date is Monday, June 29th. This represents a $0.72 annualized dividend and a dividend yield of 0.85%. Agilent Technologies’s dividend payout ratio (DPR) is 23.15%.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Featured Article: How to calculate the annual rate of depreciation
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.